Institutional shares held 45.3 Million
252K calls
72.5K puts
Total value of holdings $355M
$1.97M calls
$566K puts
Market Cap $482M
61,664,200 Shares Out.
Institutional ownership 73.53%
# of Institutions 160


Latest Institutional Activity in BVS

Top Purchases

Q1 2025
Harbor Capital Advisors, Inc. Shares Held: 21.9K ($171K)
Q1 2025
Summit Global Investments Shares Held: 54.8K ($428K)
Q1 2025
Parallel Advisors, LLC Shares Held: 36 ($282)
Q4 2024
Vanguard Group Inc Shares Held: 2.46M ($19.3M)
Q4 2024
State Street Corp Shares Held: 987K ($7.72M)

Top Sells

Q1 2025
Gamma Investing LLC Shares Held: 633 ($4.95K)
Q1 2025
Sg Americas Securities, LLC Shares Held: 14K ($110K)
Q1 2025
Rhumbline Advisers Shares Held: 54K ($422K)
Q4 2024
Morgan Stanley Shares Held: 643K ($5.03M)
Q4 2024
Nantahala Capital Management, LLC Shares Held: 4.03M ($31.5M)

About BVS

Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral nerve stimulation products. Its surgical solutions comprise bone graft substitutes to fuse and grow bones, enhance results following spinal and other orthopedic surgeries; and ultrasonic medical devices for the use in precise bone sculpting, remove tumors, and tissue debridement. The company's restorative therapies include an ultrasonic bone healing system for fracture care; skin allografts; and products that are used to support healing of chronic wounds, as well as advanced rehabilitation devices designed to help patients regain leg or hand function. It serves physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine, and neurosurgery in the physician's office or clinic, ambulatory surgical centers, or in the hospital setting. The company was founded in 2011 and is headquartered in Durham, North Carolina.


Insider Transactions at BVS

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
802K Shares
From 14 Insiders
Exercise of conversion of derivative security 696K shares
Open market or private purchase 106K shares
Sell / Disposition
129K Shares
From 4 Insiders
Open market or private sale 129K shares

Track Institutional and Insider Activities on BVS

Follow Bioventus Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BVS shares.

Notify only if
Any

Insider Trading

Get notified when an Bioventus Inc. insider buys or sells BVS shares.

Notify only if
Any
Any
P - Open market or private purchase×
S - Open market or private sale×
V - Transaction voluntarily reported earlier than required×
A - Grant, award, or other acquisition×
D - Sale (or disposition) back to the issuer×
F - Payment of exercise price or tax liability×
I - Discretionary transaction×
M - Exercise of conversion of derivative security×
C - Conversion of derivative security×
E - Expiration of short derivative position×
H - Expiration (or cancellation) of long derivative position with value received×
O - Exercise of out-of-the-money derivative securities×
X - Exercise of in-the-money or at-the-money derivatives securities×
G - Bona fide gift×
L - Small Acquisition×
W - Acquisition or disposition by will or laws×
Z - Deposit into or withdrawal from voting trust×
J - Other acquisition or disposition×
K - Transaction in equity swap or similar instrument×
U - Disposition due to a tender of shares in a change of control transaction×
20 item(s) selected

News

Receive news related to Bioventus Inc.

Track Activities on BVS